A detailed history of Empirical Finance, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Empirical Finance, LLC holds 1,310 shares of CRL stock, worth $244,039. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,310
Previous 1,257 4.22%
Holding current value
$244,039
Previous $259,000 0.39%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$187.96 - $245.29 $9,961 - $13,000
53 Added 4.22%
1,310 $258,000
Q2 2024

Jul 30, 2024

SELL
$206.39 - $268.73 $3,095 - $4,030
-15 Reduced 1.18%
1,257 $259,000
Q1 2024

May 06, 2024

BUY
$203.52 - $273.43 $18,927 - $25,428
93 Added 7.89%
1,272 $344,000
Q3 2023

Nov 02, 2023

BUY
$194.44 - $217.61 $36,554 - $40,910
188 Added 18.97%
1,179 $231,000
Q2 2023

Jul 27, 2023

BUY
$183.71 - $210.25 $182,056 - $208,357
991 New
991 $208,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.